MyFinsight
Home
Blog
About
Marketable securities
$420,039K
(-8.81%↓ Y/Y)
Cash and cash
equivalents
$120,065K
(29.89%↑ Y/Y)
Gross carrying amount
$69,320K
(-23.94%↓ Y/Y)
Total cash, cash
equivalents, and marketable...
$540,104K
(-2.35%↓ Y/Y)
Other current assets
$95,529K
(-18.18%↓ Y/Y)
Restricted cash
$25,000K
(0.00%↑ Y/Y)
Accounts and accrued
receivable
$18,597K
(-60.69%↓ Y/Y)
Property and equipment,
net
$416,677K
(-1.73%↓ Y/Y)
Investments in equity
accounted investees
$65,229K
(-27.82%↓ Y/Y)
Other long-term
assets
$62,103K
(8.09%↑ Y/Y)
Goodwill
$47,806K
(0.00%↑ Y/Y)
Intangible assets, net
$36,530K
(-9.27%↓ Y/Y)
Accumulated amortization
$32,790K
(-35.54%↓ Y/Y)
Total current assets
$679,230K
(-8.48%↓ Y/Y)
Total long-term
assets
$628,345K
(-4.78%↓ Y/Y)
Total assets
$1,307,575K
(-6.74%↓ Y/Y)
Total liabilities and
shareholders' equity
$1,307,575K
(-6.74%↓ Y/Y)
Total shareholders'
equity
$896,020K
(-11.03%↓ Y/Y)
Total liabilities
$411,555K
(4.20%↑ Y/Y)
Accumulated deficit
-$128,074K
(-450.10%↓ Y/Y)
Accumulated other
comprehensive loss
-$3,152K
(-18.63%↓ Y/Y)
Common shares no par
value, unlimited...
$821,242K
(3.74%↑ Y/Y)
Additional paid-in capital
$206,004K
(13.51%↑ Y/Y)
Total long-term
liabilities
$358,366K
(9.27%↑ Y/Y)
Total current
liabilities
$53,189K
(-20.64%↓ Y/Y)
Deferred government
contributions
$178,254K
(6.40%↑ Y/Y)
Operating lease liability
$129,948K
(-5.27%↓ Y/Y)
Deferred revenue
$40,450K
(247.72%↑ Y/Y)
Other long-term
liabilities
$9,714K
(522.69%↑ Y/Y)
Accounts payable and
other current...
$32,484K
(-35.13%↓ Y/Y)
Deferred revenue
$20,705K
(22.16%↑ Y/Y)
Back
Back
Balance Sheet
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)
source: myfinsight.com